Diagnosing, treating and managing carcinoid tumours.
Carcinoid tumours are slow-developing, rare, malignant, hormone-secreting tumours. This article discusses their diagnosis, treatment and symptom management and highlights the need for a multidisciplinary approach to patient care.
Burgess
Andrea
A
Christie Hospital NHS Trust Manchester.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000652:urine; D002276:Carcinoid Tumor / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000628:therapy* / Q000652:urine; D053379:Chromogranin A; D002864:Chromogranins / Q000097:blood; D003863:Depression / Q000209:etiology / Q000628:therapy; D003967:Diarrhea / Q000209:etiology / Q000628:therapy; D005483:Flushing / Q000209:etiology / Q000628:therapy; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D016898:Interferon-alpha / Q000627:therapeutic use; D010146:Pain / Q000209:etiology; D059408:Pain Management; D010353:Patient Education as Topic / Q000379:methods; D011878:Radiotherapy; D012135:Respiratory Sounds / Q000209:etiology; D012894:Sleep Stages; D013004:Somatostatin / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D053379:Chromogranin A; D002864:Chromogranins; D016898:Interferon-alpha; D013004:Somatostatin; D006897:Hydroxyindoleacetic Acid